1 |
Gupta, A., Lotan, Y., Ashfaq, R., Roehrborn, C. G., Raj, G. V., Aragaki, C. C., Montorsi, F. and Shariat, S. F. (2009) Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. Eur. Urol. 55, 1124-1133.
DOI
ScienceOn
|
2 |
Gutman, A. B. and Gutman, E. B. (1938) An "acid" phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland. J. Clin. Invest. 17, 473-478.
DOI
|
3 |
Harvey, A. M., Grice, B., Hamilton, C., Truong, L. D., Ro, J. Y., Ayala, A. G. and Zhai, Q. J. (2010) Diagnostic utility of P504S/p63 cocktail, prostate-specific antigen, and prostatic acid phosphatase in verifying prostatic carcinoma involvement in seminal vesicles: a study of 57 cases of radical prostatectomy specimens of pathologic stage pT3b. Arch. Pathol. Lab. Med. 134, 983-988.
|
4 |
Hassan, M. I., Aijaz, A. and Ahmad, F. (2010) Structural and functional analysis of human prostatic acid phosphatase. Expert. Rev. Anticancer Ther. 10, 1055-1068.
DOI
ScienceOn
|
5 |
Hobisch, A., Eder, I. E., Putz, T., Horninger, W., Bartsch, G., Klocker, H. and Culig Z. (1998) Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res. 58, 4640-4645.
|
6 |
Hong, S., Klein, E. A., Das Gupta, J., Hanke, K., Weight, C. J., Nguyen, C., Gaughan, C., Kim, K. A., Bannert, N., Kirchhoff, F., Munch, J. and Silverman, R. H. (2009) Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate. J. Virol. 83, 6995-7003.
DOI
ScienceOn
|
7 |
Hsing, A. W. and Chokkalingam, A. P. (2006) Prostate cancer epidemiology. Front. Biosci. 11, 1388-1413.
DOI
ScienceOn
|
8 |
Huang, C. L., Brassil, D., Rozzell, M., Schellhammer, P. F. and Wright, G. L. Jr. (1993) Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma. Prostate 23, 201-212.
DOI
ScienceOn
|
9 |
Hubert, R. S., Vivanco, I., Chen, E., Rastegar, S., Leong, K., Mitchell, S. C., Madraswala, R., Zhou, Y., Kuo, J., Raitano, A. B., Jakobovits, A., Saffran, D. C. and Afar, D. E. (1999) STEAP: A prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc. Natl. Acad. Sci. USA 96, 14523-14528.
DOI
|
10 |
Hurt, J. K., Fitzpatrick, B. J. Norris-Drouin, J. and Zylka, M. J. (2012a) Secretion and N-linked glycosylation are required for prostatic acid phosphatase catalytic and antinociceptive activity. PLoS One 7, e32741.
DOI
|
11 |
Hurt, J. K. and Zylka, M. J. (2012b) PAPupuncture has localized and long-lasting antinociceptive effects in mouse models of acute and chronic pain. Mol. Pain. 8, 28.
DOI
|
12 |
Jakob, C. G., Lewinski, K., Kuciel, R., Ostrowski, W. and Lebioda, L. (2000) Crystal structure of human prostatic acid phosphatase. Prostate 42, 211-218.
DOI
|
13 |
Kong, H. Y., Lee, H. J. and Byun, J. (2011) Roles of prostatic acid phosphatase in prostate cancer. J. Life Sci. 21, 893-900.
DOI
ScienceOn
|
14 |
Korkmaz, C. G., Korkmaz, K. S., Kurys, P., Elbi, C., Wang, L., Klokk, T. I., Hammarstrom, C., Troen, G., Svindland, A., Hager, G. L. and Saatcioglu, F. (2005) Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer. Oncogene 24, 4934-4945.
DOI
ScienceOn
|
15 |
Kuciel, R., Bakalova, A., Mazurkiewicz, A., Bilska, A. and Ostrowski, W. (1990) Is the subunit of prostatic phosphatase active?Reversible denaturation of prostatic acid phosphatase. Biochem. Int. 22, 329-334.
DOI
ScienceOn
|
16 |
Korkmaz, K. S.,, Elbi, C., Korkmaz, C. G., Loda, M., Hager, G. L. and Saatcioglu, F. (2002) Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J. Biol. Chem. 277, 36689-36696.
DOI
ScienceOn
|
17 |
Kraus, T. S., Cohen, C. and Siddiqui, M. T. (2010) Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma. Diagn. Pathol. 5, 63.
DOI
ScienceOn
|
18 |
Kristiansen, G., Fritzsche, F. R., Wassermann, K., Jäger, C., Tölls, A., Lein, M., Stephan, C., Jung, K., Pilarsky, C., Dietel, M. and Moch, H. (2008) GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br. J. Cancer 99, 939-948.
DOI
ScienceOn
|
19 |
Larne, O., Martens-Uzunova, E., Hagman, Z., Edsjo, A., Lippolis, G., den Berg, M. S., Bjartell, A., Jenster, G. and Ceder, Y. (2012) miQ - a novel microRNA based diagnostic and prognostic tool for prostate cancer. Int. J. Cancer doi: 10.1002/ijc.27973. [Epub ahead of print]
DOI
ScienceOn
|
20 |
Lee, H., Chu, T. M., Li, S. S. and Lee, C. L. (1991) Homodimer and heterodimer subunits of human prostatic acid phosphatase. Biochem. J. 277, 759-765.
DOI
|
21 |
Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B. and Nelson, W. G. (1994) Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA 91, 11733-11737.
DOI
ScienceOn
|
22 |
Li, T. S. and Beling, C. G. (1973) Isolation and characterization of two specific antigens of human seminal plasma. Fertil. Steril. 24, 134-144.
DOI
|
23 |
Liu, B. Q., Wu, Y. D., Li, P. H., Wei, J. X., Zhang, T. and Liu R. L. (2007) Prostate cancer antigen-1 as a potential novel marker for prostate cancer. Asian J. Androl. 9, 821-826.
DOI
ScienceOn
|
24 |
Lin, M. F., Garcia-Arenas, R., Xia, X. Z., Biela, B. and Lin, F. F. (1994) The cellular level of prostatic acid phosphatase and the growth of human prostate carcinoma cells. Differentiation 57, 143-149.
DOI
ScienceOn
|
25 |
Lin, M. F., Lee, M. S., Zhou, X. W., Andressen, J. C., Meng, T. C., Johansson, S. L., West, W. W., Taylor, R. J., Anderson, J. R. and Lin, F. F. (2001) Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells. J. Urol. 166, 1943-1950.
DOI
ScienceOn
|
26 |
Lin, M. F., Meng, T. C., Rao, P. S., Chang, C., Schonthal, A. H. and Lin, F. F. (1998) Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines. J. Biol. Chem. 273, 5939-5947.
DOI
ScienceOn
|
27 |
Lubaroff, D. M. (2012) Prostate cancer vaccines in clinical trials. Expert. Rev. Vaccines 11, 857-868.
DOI
ScienceOn
|
28 |
Madu, C. O. and Lu, Y. (2010) Novel diagnostic biomarkers for prostate cancer. J. Cancer 1, 150-177.
|
29 |
Makarov, D. V., Loeb, S., Getzenberg, R. H. and Partin, A. W. (2009) Biomarkers for prostate cancer. Ann. Rev. Medicine 60, 139-151.
DOI
ScienceOn
|
30 |
McNeel, D. G., Dunphy, E.J., Davies, J. G., Frye, T. P., Johnson, L. E., Staab, M. J., Horvath, D. L., Straus, J., Alberti, D., Marnocha, R., Liu, G., Eickhoff, J. C. and Wilding, G. (2009) Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with D0 prostate cancer. J. Clin. Oncol. 27, 4047-4054.
DOI
ScienceOn
|
31 |
Okar, D. A., Live, D. H., Devany, M. H. and Lange, A. J. (2000) Mechanism of the bisphosphatase reaction of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase probed by (1)H-(15)N NMR spectroscopy. Biochemistry 39, 9754-9762.
DOI
ScienceOn
|
32 |
Meng, T. C., Lee, M. S. and Lin, M. F. (2000) Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells. Oncogene19, 2664-2677.
DOI
ScienceOn
|
33 |
Merrick, G. S., Butler, W. M., Wallner, K. E., Allen, Z., DeFilippo, J. L. and Adamovich, E. (2005) Enzymatic prostatic acid phosphatase in the clinical staging of patients diagnosed with prostate cancer. W. V. Med. J. 101, 116-119.
|
34 |
Munch, J., Rücker, E, Ständker, L., Adermann, K., Goffinet, C., Schindler, M., Wildum, S., Chinnadurai, R., Rajan, D., Specht, A., Giménez-Gallego, G., Sánchez, P. C., Fowler, D. M., Koulov, A., Kelly, J. W., Mothes, W., Grivel, J. C., Margolis, L., Keppler, O. T., Forssmann, W. G. and Kirchhoff, F. (2007) Semen-derived amyloid-fibrils drastically enhance HIV infection. Cell 131, 1059-1071.
DOI
ScienceOn
|
35 |
Ortlund, E., LaCount, M. W. and Lebioda, L. (2003) Crystal structure of human prostatic acid phosphatase in complex with a phosphate ion and a-benzylaminobenzylphosphonic acid update the mechanistic picture and offer new insight into inhibitor design. Biochemistry 42, 383-389.
DOI
ScienceOn
|
36 |
Ostanin, K., Saeed, A. and Van Etten, R. L. (1994) Heterologous expression of human prostatic acid phosphatase and site-directed mutagenesis of the enzyme active site. J. Biol. Chem. 269, 8971-8978.
|
37 |
Ostrowski, W. S. and Kuciel, R. (1994) Human prostatic acid phosphatase: selected properties and practical applications. Clin. Chim. Acta. 226, 121-129.
DOI
ScienceOn
|
38 |
Porvari, K., Kurkela, R., Kivinen, A. and Vihko, P. (1995) Differential androgen regulation of rat prostatic acid phosphatase transcripts. Biochem. Biophys. Res. Commun. 213, 861-868.
DOI
ScienceOn
|
39 |
Reif, A. E., Schlesinger, R. M., Fish, C. A. and Robinson, C. M. (1973) Acid phosphatase isoenzymes in cancer of the prostate. Cancer 31, 689-699.
DOI
|
40 |
Quintero, I. B., Araujo, C. L., Pulkka, A. E., Wirkkala, R. S., Herrala, A. M., Eskelinen, E. L., Jokitalo, E., Hellström, P. A., Tuominen, H. J., Hirvikoski, P. P. and Vihko, P. T. (2007) Prostatic acid phosphatase is not a prostate specific target. Cancer Res. 67, 6549-6554.
DOI
ScienceOn
|
41 |
Reiter, R. E., Gu, Z., Watabe, T., Thomas, G., Szigeti, K., Davis, E., Wahl, M., Nisitani, S., Yamashiro, J., Le Beau, M. M., Loda, M. and Witte, O. N. (1998) Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc. Natl. Acad. Sci. USA 95, 1735-1740.
DOI
|
42 |
Rogers, C. G., Yan, G., Zha, S., Gonzalgo, M. L., Isaacs, W. B., Luo, J., De Marzo, A. M., Nelson, W. G. and Pavlovich, C. P. (2004) Prostate cancer detection on urinalysis for alpha methylacyl coenzyme A racemase protein. J. Urol. 172, 1501-1503.
DOI
ScienceOn
|
43 |
Roiko, K., Jänne, O. A. and Vihko, P. (1990) Primary structure of rat secretory acid phosphatase and comparison to other acid phosphatase. Gene 89, 223-229.
DOI
ScienceOn
|
44 |
Ronnberg, L., Vihko, P., Sajanti, E. and Vihko, R. (1981). Clomiphene citrate administration to normogonadotrophic subfertile men: blood hormone changes and activation of acid phosphatase in seminal fluid. Int. J. Androl. 4, 372-378.
DOI
|
45 |
Roth, T. J., Sheinin, Y., Lohse, C. M., Kuntz, S. M., Frigola, X., Inman, B. A., Krambeck, A. E., McKenney, M. E., Karnes, R. J., Blute. M. L., Cheville, J. C., Sebo, T. J. and Kwon, E. D. (2007) B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Res. 67, 7893-7900.
DOI
ScienceOn
|
46 |
Shan, J., Porvari, K. and Vihko, P. (2005) GAAAATATGATA-like elements in androgen-associated regulation of the prostatic acid phosphatasegene. J. Steroid. Biochem. Mol. Biol. 96, 245-249.
DOI
ScienceOn
|
47 |
Rubenstein, M., Hollowell, C. M. and Guinan, P. (2012) Differentiated prostatic antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against BCL-2 and EGFR. Med. Oncol. 29, 835-841.
DOI
ScienceOn
|
48 |
Saito, T., Hara, N., Kitamura, Y. and Komatsubara, S. (2007) Prostate-specific antigen/ prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer. Urology 70, 702-705.
DOI
ScienceOn
|
49 |
Shan. J., Porvari, K., Kivinen, A., Patrikainen, L., Halmekytö, M., Jänne, J. and Vihko, P. (2003) Tissue-specific expression of the prostatic acid phosphatase promoter constructs. Biochem. Biophys. Res. Commun. 311, 864-869.
DOI
ScienceOn
|
50 |
Shariat, S. F., Scherr, D. S., Gupta, A., Bianco, F. J. Jr, Karakiewicz, P. I., Zeltser, I. S., Samadi, D. B. and Akhavan, A. (2011) Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis. Arch. Esp. Urol. 64, 681-694.
|
51 |
Sharma, S. and Juffer, A. H. (2009) Hydrolysis of phosphohistidine in water and in prostatic acid phosphatase. Chem. Commun (Camb). 14, 6385-6387.
|
52 |
Sheftic, S., R., Snell, J., M., Jha, S. and Alexandrescu, A. T. (2012) Inhibition of semen-derived enhancer of virus infection (SEVI) fibrillogenesis by zinc and copper. Eur. Biophys J. 41, 695-704.
DOI
|
53 |
Sheridan, T., Herawi, M., Epstein, J. I. and Illei, P. B. (2007) The role of P501S and PSA in diagnosis of metastatic adenocarcinoma of the prostate. Am. J. Surg. Pathol. 31, 1351-1355.
DOI
ScienceOn
|
54 |
Azumi, N., Traweek, S. T. and Battifora, H. (1991) Prostatic acid phosphatase in carcinoid tumors: Immunohistochemical and immunoblot studies. Am. J. Surg. Pathol. 15, 758-790.
|
55 |
Abrahamsson, P. A., Lilja, H., Falkmer, S. and Wadstrom, L. B. (1988) Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate 12, 39-46.
DOI
ScienceOn
|
56 |
Afzal, S., Ahmad, M., Mushtaq, S., Mubarik, A., Qureshi, A. H. and Khan, S. A. (2003) Morphological features correlation with serum tumor markers in prostatic carcinoma. J. Coll. Physicians. Surg. Pak. 13, 511-514.
|
57 |
Antonarakis, E. S. and Drake, C. G., (2010) Current status of immunological therapies for prostate cancer. Curr. Opin. Urol. 20, 241-246.
DOI
ScienceOn
|
58 |
Batta, A., Panag, KMDS. and Singh, J. (2012) Diagnosis of prostate cancer --- Role of biomarkers. Int. J. Cur. Biomed. Phar. Res. 2, 339-345.
|
59 |
Batta, A., Panag, KMDS. and Singh, J. (2012) Diagnosis of prostate cancer --- Role of biomarkers. Int. J. Cur. Biomed. Phar. Res. 2, 339-345.
|
60 |
Brawer, M. K., Chetner, M. P., Beatie, J., Buchner, D. M., Vessella, R. L. and Lange, P. H. (1992) Screening for prostatic carcinoma with prostate specific antigen. J. Urol. 147, 841-845.
DOI
|
61 |
Solin, T., Kontturi, M., Pohlmann, R. and Vihko, P. (1990) Gene expression and prostate specificity of human prostatic acid phosphatase (PAP) : evaluation by RNA blot analyses. Biochim. Biophys. Acta. 1048, 72-77.
DOI
ScienceOn
|
62 |
Sims, R. B. (2012) Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer. Vaccine 30, 4394-4397.
DOI
ScienceOn
|
63 |
Singh, G., Adaikan, P. G. and Ng, Y. K. (1996) Is seminal prostatic acid phosphatase a reliable marker for male infertility? Singapore Med. J. 37, 598-599.
|
64 |
Small, E. J., Schellhammer, P. F., Higano, C. S., Redfern, C. H., Nemunaitis, J. J., Valone, F. H., Verjee, S. S., Jones, L. A. and Hershberg, R. M. (2006) Placebo-controlled Phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. J. Clin. Oncol. 24, 3089-3094.
DOI
ScienceOn
|
65 |
Sowa, N. A., Street, S. E., Vihko, P. and Zylka, M. J. (2010) Prostatic acid phosphatase reduces thermal sensitivity and chronic pain sensitization by depleting phosphatidylinositol 4,5-bisphosphate. J. Neurosci. 30, 10282-10293.
DOI
ScienceOn
|
66 |
Sowa, N. A., Vadakkan, K. I. and Zylka, M. J. (2009) Recombinant mouse PAP has pH-dependent ectonucleotidase activity and acts through A(1)-adenosine receptors to mediate antinociception. PLoS One 4, e4248.
DOI
ScienceOn
|
67 |
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., Nyati, M. K., Ahsan, A., Kalyana-Sundaram, S., Han, B., Cao, X., Byun, J., Omenn, G. S., Ghosh, D., Pennathur, S., Alexander, D. C., Berger, A., Shuster, J. R., Wei, J. T., Varambally, S., Beecher, C. and Chinnaiyan, A. M. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914.
DOI
ScienceOn
|
68 |
Chen, H., Pong, R. C., Wang, Z. and Hsieh, J. T. (2002) Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization. Genomics 79, 573-581.
DOI
ScienceOn
|
69 |
Bussemakers, M. J., van Bokhoven, A., Verhaegh, G. W., Smit, F. P., Karthaus, H. F., Schalken, J. A., Debruyne, F. M., Ru, N. and Isaacs, W. B. (1999) DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 59, 5975-5979.
|
70 |
Cheever, M. A. and Higano, C. S. (2011) PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. Clin. Cancer Res. 17, 3520-3526.
DOI
|
71 |
Collins, K. A. and Bennett, A. T. (2011) Persistence of spermatozoa and prostatic acid phosphatase in specimens from decreased individuals during varied postmortem intervals. Am. J. Forensic Med. Pathol. 22, 228-232.
|
72 |
Coussens, L. M. and Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867.
DOI
ScienceOn
|
73 |
Dave, B. N. and Rindani, T. H. (1988) Acid phosphatase activity in human semen. Int. J. Fertil. 33, 45-47.
|
74 |
Deftos, L. J. (1998) Granin-A, parathyroid hormone-related protein, and calcitonin gene products in neuroendocrine prostate cancer. Prostate Suppl. 8, 23-31.
|
75 |
Drake, C. G. (2010) Prostate cancer as a model for tumour immunotherapy. Nat. Rev. Immunol. 10, 580-593.
DOI
ScienceOn
|
76 |
Drake, C. G. (2012) Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer. J. Natl. Cancer Inst. 104, 1422.
|
77 |
Erbas, H., Erten, O. and Irfanoglu, M. E. (2007) Prostatic acid phosphatase in breast cyst fluid. Malays. J. Pathol. 29, 95-99.
|
78 |
Taira, A., Merrick, G., Wallner, K. and Dattoli, M. (2007) Reviving the acid phosphatase test for prostate cancer. Oncology 21, 1003-1010.
|
79 |
Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. and Redwine, E. (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 317, 909-916.
DOI
ScienceOn
|
80 |
Street, S. E., Walsh, P. L., Sowa, N. A., Taylor-Blake, B., Guillot, T. S., Vihko, P., Wightman, R. M. and Zylka, M. J. (2011) PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine. Mol. Pain 7, 80.
DOI
|
81 |
Tasken, K. A., Angelsen, A., Svindland, A., Eide, T., Berge, V., Wahlquist, R. and Karlsen, S. (2005) Markers for diagnosis, prediction and prognosis of prostate cancer. Tidsskr. Nor. Laegeforen. 125, 3279-3282.
|
82 |
Thompson, T. C., Tahir, S. A., Li, L., Watanabe, M., Naruishi, K., Yang, G., Kadmon, D., Logothetis, C. J., Troncoso, P., Ren, C., Goltsov, A. and Park, S. (2010) The role of caveolin-1 in prostate cancer: clinical implications. Prostate Cancer Prostatic. Dis. 13, 6-11.
DOI
ScienceOn
|
83 |
Tian, W., Osawa, M., Horiuchi, H. and Tomita, Y. (2004) Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate. Cancer Sci. 95, 491-495.
DOI
ScienceOn
|
84 |
Truong, L. D., Kadmon, D., McCune, B. K., Flanders, K. C., Scardino, P. T. and Thompson, T. C. (1993) Association of transforming growth factor-beta 1 with prostate cancer: An immunohistochemical study. Hum. Pathol. 24, 4-9.
DOI
ScienceOn
|
85 |
Van Etten, R. L. (1982) Human prostatic acid phosphatase: a histidine phosphatase. Ann. N. Y. Acad. Sci. 390, 27-51.
DOI
|
86 |
Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U. and Stein, H. (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133, 1710-1715.
|
87 |
Ercole, C. J., Lange, P. H., Mathisen, M., Chiou, R. K., Reddy, P. K. and Vessella, R. L. (1987) Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. J. Urol. 138, 1181-1184.
DOI
|
88 |
Fang, L.C., Dattoli, M., Taira, A., True, L., Sorace, R. and Wallner K. (2008) Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy. Urology 71, 146-150.
DOI
ScienceOn
|
89 |
Garcia, J. A. (2011) Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: an insight for oncologists. Ther. Adv. Med. Oncol. 3, 101-108.
DOI
|
90 |
Gerritsen, W. R. (2012) The evolving role of immunotherapy in prostate cancer. Ann. Oncol. 23, viii22-27.
DOI
ScienceOn
|
91 |
Getzenberg, R. H., Pienta, K. J., Huang, E. Y. and Coffey, D. S. (1991) Identification of nuclear matrix proteins in the cancer and normal rat prostate. Cancer Res. 51, 6514-6520.
|
92 |
Goldfarb, D. A., Stein, B. S., Shamszadeh, M. and Petersen, R. O. (1986) Age-related changes in tissue level of prostatic acid phosphatase and prostate specific antigen. J. Urol. 136, 1266-1269.
DOI
|
93 |
Graddis, T. J., McMahan, C. J., Tamman, J., Page, K. J. and Trager, J. B. (2011) Prostatic acid phosphatase expression in human tissues. Int. J. Clin. Exp. Pathol. 4, 295-306.
|
94 |
Gunia, S., Koch, S., May, M., Dietel, M. and Erbersdobler, A. (2009) Expression of prostatic acid phosphatase (PSAP) in transurethral resection specimens of the prostate is predictive of histopathologic tumor stage in subsequent radical prostatectomies. Virchows. Arch. 454, 573-579.
DOI
|
95 |
Vieweg, J. and Dannull, J. (2005) Technology insight: vaccine therapy for prostate cancer. Nat. Clin. Pract. Urol. 2, 44-51.
DOI
ScienceOn
|
96 |
Van Etten, R. L., Davidson, R., Stevis, P. E., MacArthur, H. and Moore, D. L. (1991) Covalent structure, disulfide binding, and identification of reactive surface and active site residues of human prostatic acid phosphatase. J. Biol. Chem. 266, 2313-2319.
|
97 |
Vanaja, D. K., Ballman, K. V., Morlan, B. W., Cheville, J. C., Neumann, R. M., Lieber, M. M., Tindall, D. J. and Young, C. Y. (2006) PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer. Clin. Cancer Res. 12, 1128-1136.
DOI
ScienceOn
|
98 |
Veeramani, S., Yuan, T. C., Chen, S. J., Lin, F. F., Petersen, J. E., Shaheduzzaman, S., Srivastava, S., MacDonald, R. G. and Lin, M. F. (2005) Cellular prostatic acid phosphatase : a protein tyrosine phosphatase involved in androgen-independent proliferation of phosphatase. Endocr. Relat. Cancer 12, 805-822.
DOI
ScienceOn
|
99 |
Vihko, P., Herrala, A., Härkönen, P., Isomaa, V., Kaija, H., Kurkela, R., Li, Y., Patrikainen, L., Pulkka, A., Soronen, P. and Torn, S. (2005) Enzymes as modulators in malignant transformation. J. Steroid Biochem. Mol. Biol. 93, 277-283.
DOI
ScienceOn
|
100 |
Vihko, P., Kontturi, M. and Korhonen, L. K. (1978) Purification of human prostatic acid phosphatase by affinity chromatography and isoelectric focusing. Part I. Clin. Chem. 24, 466-470.
|
101 |
Wang, Y., Harada, M., Yano, H., Ogasawara, S., Takedatsu, H., Arima, Y., Matsueda, S., Yamada, A. and Itoh, K. (2005) Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with nonprostate adenocarcinoma. J. Immunother. 28, 535-541.
DOI
|
102 |
Wikstrom, P., Lissbrant, I. F., Stattin, P., Egevad, L. and Bergh, A. (2002) Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate 51, 268-275.
DOI
ScienceOn
|
103 |
Zelivianski, S., Glowacki, R. and Lin, M. F. (2004) Transcriptional activation of the human prostatic acid phosphatase gene by NF- via a novel hexanucleotide-binding site. Nucleic. Acid. Res. 32, 3566-3580.
DOI
ScienceOn
|
104 |
Winqvist, R., Virkkunen, P., Grzeschik, K. H. and Vihko, P. (1989) Chromosomal localization to 3q21----qter and two TaqI RFLPs of the human prostatic-specific acid phosphatase gene (ACPP). Cytogenet. Cell Genet. 52, 68-71.
DOI
|
105 |
Young, A., Palanisamy, N., Siddiqui, J., Wood, D., P., Wei, J., T., Chinnaiyan., A. M., Kunju, L., P. and Tomlins, S. A. (2012) Correlation of Urine TMPRSS2:ERG and PCA3 to ERG+ and Total Prostate Cancer Burden. Am. J. Clin. Pathol. 138, 685-696.
DOI
|
106 |
Zelivianski, S., Comeau, D. and Lin, M. F. (1998) Cloning and analysis of the promoter activity of the human prostatic acid phosphatase gene. Biochem. Biophys. Res. Commun. 245, 108-112.
DOI
ScienceOn
|
107 |
Zhang, X. Q., Lee, M. S., Zelivianski, S. and Lin, M. F. (2001) Characterization of a prostate-specific tyrosine phosphatase by mutagenesis and expression in human prostate cancer cells. J. Biol. Chem. 276, 2544-2550.
DOI
ScienceOn
|
108 |
Zimmermann, H. (2009) Prostatic acid phosphatase, a neglected ectonucleotidase. Purinergic Signal. 5, 273-275
DOI
|
109 |
Zylka, M. J., Sowa, N. A., Taylor-Blake, B., Twomey, M. A., Herrala, A., Voikar, V. and Vihko P. (2008) Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine. Neuron 60, 111-122.
DOI
ScienceOn
|